Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Humble Group - Ready and set for acquisitions in 2025

19 februari 2025

<a id="bm-comp-141bf28f-e5cc-4325-b25a-c3ef108e6940" name="bm-comp-141bf28f-e5cc-4325-b25a-c3ef108e6940" class="BMCustomAnchor"></a><table><tr><td bm-component-id="141bf28f-e5cc-4325-b25a-c3ef108e6940" style="vertical-align: top; width:100.000000%;"><ul><li>Sales in line with cons, adj. EBITA -7% vs cons</li><li>Consensus EBITA estimate revisions slightly negative</li><li>Acquisitions back on the agenda again</li></ul></td></tr></table><a id="bm-comp-09e5145f-3ab8-48ac-ac8a-8ad3de3b12d8" name="bm-comp-09e5145f-3ab8-48ac-ac8a-8ad3de3b12d8" class="BMCustomAnchor"></a><table><tr><td bm-component-id="09e5145f-3ab8-48ac-ac8a-8ad3de3b12d8" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q4'24 outcome</h3><p>The Q4 report was mostly in line with expectations. Q4 sales came in at SEK 2,089m (0% vs ABGSCe 2,098m, 0% vs cons 2,099m), organic growth ~7% (vs 8% ABGSCe; vs 8% cons), gross margin at 31.5% (vs ABGSCe 31.0%, vs cons 31.1%) and adj. EBITA at 157m (0% vs ABGSCe 157m, -7% vs cons 168m). Humble's gross margin was slightly better than expected, but the capacity-increasing investments weigh on adj. EBITA, causing a slight miss vs consensus.</p><h3 class="bm-h3">Thoughts and outlook</h3><p>Organic growth is strong at 7% considering a tough comparable figure of 18%. While EBITA growth was hampered by a somewhat higher opex base, the gross margin is intact. This means that Humble can scale on EBITA once its opex investments are concluded. Interestingly, M&amp;A seems to be back on the agenda as the company is deleveraging. For Humble's platform companies (e.g., Solent), this should be positive as they will be allowed to grab additional market share and compound earnings at a higher rate. Our opinion on the business is unchanged but positive following the report.</p><h3 class="bm-h3">We expect minor, negative consensus estimate revisions</h3><p>The share is down ~8% YTD and is trading at ~9x '25e EV/EBITA on our unrevised estimates. Mechanically, EBITA consensus estimates should come down by low single-digits. Conference call at 10:00 CET (<a href="https://humble-group.events.inderes.com/q4-report-2024" target="_blank">link</a>).</p><table id="bm-img-1d746af6-1a09-4b57-9bc6-181f5e765de9" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="1d746af6-1a09-4b57-9bc6-181f5e765de9" bm-img-original-height="313" bm-img-original-width="1142" bm-img-svg="image:image_upload/85655_3c3e3be0-d67a-4bb3-8034-e3f6a597bba9.svg" bm-img-width-hint="100%" id="bm-id-1d746af6-1a09-4b57-9bc6-181f5e765de9" src="https://abgsc.bluematrix.com/images/image_upload/85655_3c3e3be0-d67a-4bb3-8034-e3f6a597bba9_733.png" svg="/nas/web/clients/abgsc/images/image_upload/85655_3c3e3be0-d67a-4bb3-8034-e3f6a597bba9.svg" width="727" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, Company data, FactSet.</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-04-01 Careium - Entering a growth-focused period Careium Analys
2026-04-01 Medicover - Weather is set to be a drag Medicover Analys
2026-03-31 Midsona - Skipping down Sesame Street Midsona Analys
2026-03-31 Petrolia Noco - Brage builds momentum into 2026 Petrolia Noco Analys
2026-03-30 Cavotec - Industry leading the way Cavotec Analys
2026-03-30 Impact Coatings - Waiting for renewed momentum Impact Coat.. Analys
2026-03-30 I-tech - Another growth breather in Q1e I-tech Analys
2026-03-24 Donkey Republic - A donkey worth riding Donkey Repu.. Analys
2026-03-20 Coor - CMD added confidence in margin target Coor Analys
2026-03-16 Xplora Technologies - Acquires DACH's leading sen... Xplora Tech.. Analys
2026-03-12 StrongPoint - Investor update StrongPoint Analys
2026-03-08 Medicover - From build-out to fill-up Medicover Analys
2026-03-02 Qben Infra - Portfolio reshaping continues Qben Infra Analys
2026-02-27 Xplora Technologies - Record quarter driven by Se... Xplora Tech.. Analys
2026-02-24 Isofol Medical - From first lessons to second exe... Isofol Medical Analys
2026-02-24 B3 Consulting Group - Cost adjustments should lif... B3 Consulti.. Analys
2026-02-23 Ework Group - Market conditions yet to improve Ework Group Analys
2026-02-23 Formpipe - Good margins, but ACV lags Formpipe Analys
2026-02-23 Energy Save - Back to growth, but softer H1'26 ex... Energy Save Analys
2026-02-23 Fastpartner - Outlook taking a hit Fastpartner Analys